It isn’t often a sector unquestioningly excels in internal practices, but Tom O'Byrne, chief executive of Great Place to Work UK, considers, in an Expert View piece, its recent insights on how the pharmaceutical and biotech sector is achieving this and leading the way in employee engagement.
Here at Great Place to Work, through engagement with several key pharma and biotech organizations including Bayer (BAYN: DE), AbbVie (NYSE: ABBV) and Medtronic (NYSE: MDT), we have drawn some intriguing conclusions about the sector and its approach to its employees.
There are a number of key indicators of employee engagement, among them staff absenteeism and retention rate. In both of these areas, the sector demonstrates outstanding results.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze